Forums before death by AOL, social media and spammers... "We can't have nice things"
|    talk.politics.medicine    |    talk.politics.medicine    |    20,937 messages    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
|    Message 20,291 of 20,937    |
|    David Fritz to All    |
|    5 Crook Doctors Are Charged With Taking     |
|    19 Mar 18 02:16:03    |
      XPost: alt.drugs.hard, sac.politics, alt.politics.usa.republican       XPost: alt.politics.economics       From: david.fritz@vzw.com              In March of 2013, Gordon Freedman, a doctor on Manhattan’s Upper East       Side, fielded a request from a regional sales manager for the manufacturer       of Subsys, a spray form of the highly addictive painkiller fentanyl.              Dr. Freedman was already a top prescriber of Subsys and also one of the       company’s paid promotional speakers. Now the sales manager was telling him       the company, Insys Therapeutics, would increase the amount of money it was       paying him and asked that he increase the number of new patients he was       prescribing Subsys.              “Got it,” Dr. Freedman replied, according to authorities. By 2014, they       said, Dr. Freedman had become one of the country’s top prescribers of the       painkiller drug — and also the company’s highest-paid speaker.              The exchange between the doctor and Insys was detailed in a federal       indictment unsealed on Friday in Manhattan, charging Dr. Freedman, of       Mount Kisco, N.Y., and four other New York doctors with participating in a       bribery and kickback scheme that prosecutors said sought to increase the       drug company’s sales and preyed on unwitting patients.              Insys paid the doctors, in some cases more than $100,000 annually, in       return for prescribing millions of dollars’ worth of the company’s       painkiller product, the indictment said. It charged that Insys funneled       the illicit payments to the doctors through a sham “speakers bureau,” in       which the doctors were paid for purportedly giving educational       presentations about the drug that, in many cases, were mere social       gatherings at high-end Manhattan restaurants.              Such gatherings involved no educational presentation, and attendance sign-       in sheets were often forged to include the names of health care       practitioners who were not actually present, the authorities said.              “These prominent doctors swore a solemn oath to place their patients’ care       above all else,” said Geoffrey S. Berman, the United States attorney for       the Southern District of New York. “Instead, they engaged in a malignant       scheme to prescribe fentanyl, a dangerous and potentially fatal narcotic       50 to 100 times more potent than morphine, in exchange for bribes in the       form of speaker fees.”              Mr. Berman announced the charges along with William F. Sweeney Jr., the       head of the F.B.I.’s New York office. The four other doctors charged in       the New York case are Jeffrey Goldstein of New Rochelle, N.Y.; Todd       Schlifstein of New York City; Dialecti Voudouris of New York City; and       Alexandru Burducea of Little Neck, N.Y.              All five defendants pleaded not guilty in federal court on Friday       afternoon and were released on $200,000 bond. None of the five responded       to reporters’ requests for comment as they left the courtroom.              Mr. Berman’s office also disclosed that two former Insys employees —       Jonathan Roper and Fernando Serrano — had pleaded guilty and were       cooperating with the federal investigation.              Insys, which is based in Arizona, has come under intense scrutiny over its       aggressive marketing of Subsys, a form of fentanyl approved in 2012.       Subsys is sprayed under the tongue and approved for use only in patients       who have cancer and who experience pain even though they are already on       round-the-clock painkillers.              Fentanyl can be deadly if it is prescribed in large doses to someone who       has not already become tolerant to opioids, yet the drug has been widely       sold to a variety of patients. An analysis in 2014 for The New York Times       by the research firm Symphony Health, for example, found that just 1       percent of prescriptions for Subsys were from oncologists.              Already, the federal authorities in Boston have brought charges against       Insys’s founder and former chief executive, John Kapoor, as well as       against several other top executives and sales managers. They have all       pleaded not guilty.              The New York indictment offers further evidence that investigators have       broadened their inquiry into doctors who were prescribing the drug to       patients. Earlier this month, another top prescriber, Jerrold Rosenberg of       Rhode Island, was sentenced to more than four years in prison after       admitting he took kickbacks from Insys.              The company did not respond to a request for comment on Friday.              The indictment unsealed on Friday charged that the drug firm had used its       speakers program "to induce a select group of practitioners,” including       the five doctors charged in New York, to prescribe large volumes of the       fentanyl spray. The selected doctors were often referred to within the       company as “top docs,” the indictment said.              The company’s executives meticulously “tracked and circulated statistics       for each speaker,” the indictment noted.              It also said Mr. Roper, then the district sales manager for a territory       that included Manhattan, emailed sales representatives, reminding them to       repeatedly tell their speakers of “one simple guideline” — if they did not       write prescriptions, there would be no speaking engagements. As he put it,       according to the indictment: “NO SCRIPTS. NO PROGRAMS.”              One of the defendants, Dr. Goldstein, sometimes did not even stay for a       meal at the programs where he was the featured speaker, instead ordering       food from the restaurant and leaving with it, according to the indictment.              Before one program in 2014, the indictment added, Dr. Goldstein wrote to       an Insys sales representative, asking, “Is dinner take out or we expecting       peeps?”              https://www.nytimes.com/2018/03/16/nyregion/fentanyl-subsys-drug-       kickbacks.html              --- SoupGate-Win32 v1.05        * Origin: you cannot sedate... all the things you hate (1:229/2)    |
[   << oldest   |   < older   |   list   |   newer >   |   newest >>   ]
(c) 1994, bbs@darkrealms.ca